^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

MMP2 elevation

i
Other names: MMP2, CLG4, CLG4A, TBE-1, Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
Entrez ID:
Related biomarkers:
7ms
STAT3 promotes migration and invasion of cholangiocarcinoma arising from choledochal cyst by transcriptionally inhibiting miR200c through the c-myb/MEK/ERK signaling pathway. (PubMed, Cell Mol Biol (Noisy-le-grand))
MEK activator significantly reversed the inactivation of the MEK/ERK pathway induced by si-STAT3+miR200c inhibitor+si-c-Myb. In summary, the silence of STAT3 suppressed metastasis and progression of CCA cells by regulating miR200c through the c-Myb mediated MEK/ERK pathway, suggesting STAT3 is the effective target for CCA arising from CC.
Journal
|
CDH1 (Cadherin 1) • STAT3 (Signal Transducer And Activator Of Transcription 3) • MYB (MYB Proto-Oncogene, Transcription Factor) • MMP2 (Matrix metallopeptidase 2) • MIR200C (MicroRNA 200c) • VIM (Vimentin) • CDH2 (Cadherin 2) • MMP9 (Matrix metallopeptidase 9)
|
CDH1 expression • STAT3 expression • MMP2 elevation • VIM expression • miR-200-c expression • MMP9 elevation
8ms
Resveratrol Inhibits Abdominal Aortic Aneurysm Progression by Reducing Extracellular Matrix Degradation, Apoptosis, Autophagy, and Inflammation of Vascular Smooth Muscle Cells via Upregulation of HMOX1. (PubMed, J Endovasc Ther)
Our study found that angiotensin II (Ang II) stimulated increased the levels of MMP-2 and MMP-9 in vascular smooth muscle cells (VSMCs), decreased elastin expression, and promoted apoptosis, autophagy occurrence, and secretion of inflammatory factors, while resveratrol (RES) pretreatment improved this effect. In addition, downregulation of HMOX1 expression eliminated the effect of RES on the function of VSMCs. Our study elucidates that RES improves AAA progression through HMOX1 at both cellular and animal levels. This work can help doctors better understand the pathological mechanism of the occurrence and development of AAA, and provide a theoretical basis for clinicians to find better treatment options.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • HMOX1 (Heme Oxygenase 1) • MMP2 (Matrix metallopeptidase 2) • BAX (BCL2-associated X protein) • CASP3 (Caspase 3) • MMP9 (Matrix metallopeptidase 9) • IL1B (Interleukin 1, beta) • BECN1 (Beclin 1)
|
HMOX1 expression • MMP2 elevation
10ms
2-D Vanadium Disulfide nanosheets assisted ultrasensitive, rapid, and label-free electrochemical quantification of cancer biomarker (MMP-2). (PubMed, Nanotechnology)
Further, interference studies were also performed which demonstrates the sensor to be highly selective against non-specific target proteins. This 2-D VS2 nanosheet-based electrochemical biosensor is a sensitive, cost-effective, accurate, and selective solution for cancer diagnosis.
Journal
|
MMP2 (Matrix metallopeptidase 2)
|
MMP2 elevation
1year
CHITINASE 3-LIKE-1 PROTEIN, OSTEOPONTIN AND MATRIX METALLOPROTEINASE 2 PLASMA LEVELS ARE SIGNIFICANTLY ELEVATED IN COLORECTAL CANCER (CRC) PATIENTS; CONSIDERED TOGETHER THE 3 PROTEINS IMPROVE THE SENSITIVITY/SPECIFICITY OF PLASMA ANALYSIS FOR DIAGNOSIS (DDW 2023)
Median CHI3l1, MMP2 and OPN levels in CRC were significantly higher (183.7%, 27% & 39% respectively) vs BCP levels. Elevated PGRN and OPN levels may promote VEGF mediated vascular invasion and tumor progression while elevated MMP2 may support circulating tumor cell invasion. The combination of three vs single protein AUC results were improved and may have value as a diagnostic panel together with other CRC promoting proteins.
Clinical
|
SPP1 (Secreted Phosphoprotein 1) • MMP2 (Matrix metallopeptidase 2) • CHI3L1 (Chitinase 3-like 1)
|
MMP2 elevation
over1year
Edoxaban, a Factor Xa-Specific Direct Oral Anticoagulant, Significantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice. (PubMed, TH Open)
Materials and Methods  DOACs targeting thrombin (dabigatran etexilate [DABE]) or factor Xa (rivaroxaban [RVX] and edoxaban [EDX]) were orally administered daily to male BALB/c mice inoculated with Colon26 cells, followed by analyses of tumor growth and plasma levels of coagulation- and tumor-related factors such as tissue factor (TF), plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6), and matrix metalloproteinase-2 (MMP-2). In addition, apoptotic cells and p53 protein levels were significantly increased in tumor tissues of EDX-treated mice. Conclusion  The data suggest that among the tested DOACs, EDX significantly suppresses tumor cell proliferation via the factor Xa-PAR2 pathway, which is activated by coagulation and inflammation in Colon26-inoculated mice and induces tumor cell apoptosis.
Preclinical • Journal
|
CCND1 (Cyclin D1) • IL6 (Interleukin 6) • STAT3 (Signal Transducer And Activator Of Transcription 3) • MMP2 (Matrix metallopeptidase 2)
|
CCND1 expression • MMP2 elevation
over1year
Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy. (PubMed, Drug Deliv)
To increase the antitumor drug concentration in the liver tumor site and improve the therapeutic effects, a functionalized liposome (PPP-LIP) with tumor targetability and enhanced internalization after matrix metalloproteinase-2 (MMP2)-triggered cell-penetrating peptide (TATp) exposure was modified with myrcludex B (a synthetic HBV preS-derived lipopeptide endowed with compelling liver tropism) for liver tumor-specific delivery...Hydroxycamptothecin (HCPT)-loaded PPP-LIP showed a better antitumor effect than commercially available HCPT injections among MTT, three-dimensional (3 D) tumor ball, and tumor-bearing nude mouse experiments. Our findings indicated that PPP-LIP nanocarriers could be a promising tumor-targeted medication delivery strategy for treating liver cancers with elevated MMP2 expression.
Journal
|
MMP2 (Matrix metallopeptidase 2)
|
MMP2 elevation
almost2years
DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway. (PubMed, EBioMedicine)
Our findings demonstrate that DNTTIP1 not only regulates NPC metastasis but also independently predicts NPC prognosis. Furthermore, targeting DNTTIP1/HDAC1 by Chidamide may benefit NPC patients with metastasis.
Journal
|
MMP2 (Matrix metallopeptidase 2) • HDAC1 (Histone Deacetylase 1)
|
MMP2 elevation
|
Epidaza (chidamide)
over2years
STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling. (PubMed, Mol Biol Rep)
NCK1 may serve as a diagnostic and prognostic marker of metastatic TNBC. STAT3 upregulation promoted the expression of NCK1, which subsequently induced the migration and activity of MMPs in a ERK1/2 signaling-dependent manner in TNBC cells. NCK1 is a promising target for improving TNBC migration.
Journal
|
STAT3 (Signal Transducer And Activator Of Transcription 3) • MMP2 (Matrix metallopeptidase 2) • MMP9 (Matrix metallopeptidase 9)
|
MMP2 elevation
over2years
Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases. (PubMed, World J Gastrointest Oncol)
MMP-2 levels are elevated for 5 wk and MMP-7 levels elevated for weeks 2-6. The etiology of these changes in unclear, trauma and wound healing likely play a role. These changes may promote residual tumor growth and metastasis.
Journal
|
MMP2 (Matrix metallopeptidase 2) • MMP7 (Matrix metallopeptidase 7)
|
MMP2 elevation
3years
A Study of Matrix Metalloproteinase-2 and Interleukin-18 in Preinvasive and Invasive Lesions of Cancer Cervix. (PubMed, J Midlife Health)
Increased levels of MMP-2 and decreased circulating levels of IL-18 were found in cases. Hence, we raise an issue to study MMP-2 and IL-18 further for their diagnostic and prognostic marker role.
Journal
|
MMP2 (Matrix metallopeptidase 2) • IL18 (Interleukin 18)
|
MMP2 elevation
3years
In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer. (PubMed, BMC Urol)
Our research indicates that WWOX possesses tumor suppressor properties in bladder cancer but consecutive examination is required to entirely understand the contribution of AP-2γ or AP-2α.
Journal
|
MMP2 (Matrix metallopeptidase 2) • MMP9 (Matrix metallopeptidase 9)
|
MMP2 elevation
over3years
The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer. (PubMed, J Biosci)
Finally, rescue assay suggested that miR-139-5p restoration reversed MIAT-overexpression-induced promotion on the migration and invasion of NSCLC cells. In conclusion, our results demonstrated that lncRNA MIAT modulated the migration and invasion of NSCLC by regulating miR-139-5p and MMP2.
Journal
|
MMP2 (Matrix metallopeptidase 2) • MIR139 (MicroRNA 139)
|
MMP2 elevation • miR-139-5p expression
over3years
Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas. (PubMed, Urol Oncol)
CD44 expression may play an important role in the progression of both ccRCC and non-ccRCC. CD44 expression in ccRCC may be associated with elevated MMP2 and MMP9 expression levels, which is in contrast to non-ccRCC. The different correlations between CD44, MMP2, and MMP9 in ccRCC and non-ccRCC can be useful in understanding the mechanisms of carcinogenesis and stratifying patients for therapeutic purposes.
Journal
|
CD44 (CD44 Molecule) • MMP2 (Matrix metallopeptidase 2) • MMP9 (Matrix metallopeptidase 9)
|
CD44 expression • MMP2 elevation • MMP9 elevation
almost4years
Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a/JAK2/STAT3 signaling. (PubMed, Ann Transl Med)
IL-17a was blocked with a polyclonal antibody, and JAK2/STAT3 signaling pathway was blocked by a specific inhibitor AG490...CAFs secreted IL-17a, which promoted the migration and invasion of GC cells through activating JAK2/STAT3 signaling. These results may identify IL-17a as a promising prognostic marker and therapeutic target of GC.
Journal
|
MMP2 (Matrix metallopeptidase 2) • TIMP1 (Tissue inhibitor of metalloproteinases 1) • IL17A (Interleukin 17A) • MMP9 (Matrix metallopeptidase 9)
|
MMP2 elevation • KIM1 expression
|
tyrphostin (AG 490)
4years
The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer. (PubMed, J Gastroenterol Hepatol)
Our study suggests that HYAL1 and HYAL2 suppress CRC metastasis through regulating MMPs/TIMPs balance and rearranging F-actin distribution, further inhibiting invasion and migration of cancer cells.
Journal
|
MMP2 (Matrix metallopeptidase 2) • TIMP1 (Tissue inhibitor of metalloproteinases 1) • MMP9 (Matrix metallopeptidase 9)
|
MMP2 elevation
4years
Protection against Ultraviolet A-Induced Skin Apoptosis and Carcinogenesis through the Oxidative Stress Reduction Effects of N-(4-bromophenethyl) Caffeamide, A Propolis Derivative. (PubMed, Antioxidants (Basel))
We observed that K36H ameliorated UVA-induced oxidative stress, inflammation, apoptosis and antiphotocarcinogenic activity. K36H can potentially be used for the development of antiphotodamage and antiphotocarcinogenic products.
Journal
|
IL6 (Interleukin 6) • HMOX1 (Heme Oxygenase 1) • MMP2 (Matrix metallopeptidase 2) • CASP3 (Caspase 3)
|
MMP2 elevation
4years
Activin A target genes are differentially expressed between normal and neoplastic adult human testes: clues to gonocyte fate choice. (PubMed, Andrology)
This knowledge provides a basis for understanding how physiological changes that influence activin/TGF-β superfamily signalling may alter germ cell fate.
Clinical • Journal
|
MMP2 (Matrix metallopeptidase 2) • INHBA (Inhibin, beta A) • MMP9 (Matrix metallopeptidase 9) • CCL7 (Chemokine (C-C motif) ligand 7)
|
MMP2 elevation • MMP9 elevation